These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7082711)

  • 1. Serial dexamethasone suppression tests among rapidly cycling bipolar patients.
    Greden JF; DeVigne JP; Albala AA; Tarika J; Buttenheim M; Eiser A; Carroll BJ
    Biol Psychiatry; 1982 Apr; 17(4):455-62. PubMed ID: 7082711
    [No Abstract]   [Full Text] [Related]  

  • 2. Dexamethasone suppression test and response to MAOI treatment.
    Rihmer Z; Gombos I; Hada Z; Gyorgy S; Aroto M
    J Clin Psychiatry; 1989 Mar; 50(3):107-8. PubMed ID: 2925596
    [No Abstract]   [Full Text] [Related]  

  • 3. Symptom profile of patients with positive DST: a pilot study.
    Nasr SJ; Pandey G; Altman EG; Gibbons R; Gaviria FM; Davis JM
    Biol Psychiatry; 1983 May; 18(5):571-4. PubMed ID: 6860729
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function.
    Watson S; Thompson JM; Ritchie JC; Nicol Ferrier I; Young AH
    Bipolar Disord; 2006 Feb; 8(1):85-90. PubMed ID: 16411985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trait marker for mental illness: dexamethasone suppression test.
    Solomon JG
    Va Med; 1983 Jun; 110(6):382-6. PubMed ID: 6880370
    [No Abstract]   [Full Text] [Related]  

  • 7. Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression.
    Greden JF; Albala AA; Haskett RF; James NM; Goodman L; Steiner M; Carroll BJ
    Biol Psychiatry; 1980 Jun; 15(3):449-58. PubMed ID: 7378518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortisol suppression index: a new approach to interpreting the DST in depression.
    Bernstein JP; Chung SY; Avila KS
    J Clin Psychiatry; 1982 Dec; 43(12):476-8. PubMed ID: 7161249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference by carbamazepine with the dexamethasone suppression test.
    Privitera MR; Greden JF; Gardner RW; Ritchie JC; Carroll BJ
    Biol Psychiatry; 1982 May; 17(5):611-20. PubMed ID: 7093397
    [No Abstract]   [Full Text] [Related]  

  • 10. [The dexamethasone test and mania].
    Tan MG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):284-6. PubMed ID: 3833513
    [No Abstract]   [Full Text] [Related]  

  • 11. Bipolar illness, catatonia, and the dexamethasone suppression test in adolescence: case report.
    Hall DC; Ries RK
    J Clin Psychiatry; 1983 Jun; 44(6):222-4. PubMed ID: 6406474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J; Lammers CH; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):797-802. PubMed ID: 8750037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dex/CRH test--is it better than the DST?
    Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test in mixed bipolar disorder.
    Evans DL; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):615-7. PubMed ID: 6846594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal dexamethasone tests in withdrawing alcoholic patients.
    Targum SD; Capodanno AE; Unger S; Advani M
    Biol Psychiatry; 1984 Mar; 19(3):401-5. PubMed ID: 6722229
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms.
    Krishnan RR; Maltbie AA; Davidson JR
    Am J Psychiatry; 1983 Feb; 140(2):203-5. PubMed ID: 6849435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine evaluation of depression in borderline patients.
    Carroll BJ; Greden JF; Feinberg M; Lohr N; James NM; Steiner M; Haskett RF; Albala AA; DeVigne JP; Tarika J
    Psychiatr Clin North Am; 1981 Apr; 4(1):89-99. PubMed ID: 7232239
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma dexamethasone concentration and cortisol response during manic episodes.
    Cassidy F; Ritchie JC; Carroll BJ
    Biol Psychiatry; 1998 May; 43(10):747-54. PubMed ID: 9606529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-dexamethasone plasma cortisol levels in depressive patients receiving electro-convulsive therapy.
    Varma SL; Lal N; Trivedi JK; Anand M
    Indian J Med Res; 1988 Jan; 87():86-91. PubMed ID: 3360488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.